Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT00339859
Eligibility Criteria:
* INCLUSION CRITERIA:
* Case Subject Selection:
* Diagnosis of non-small cell lung cancer made pathologically (with confirmation by a second pathologist).
* Must reside in Baltimore city or contiguous metropolitan counties, Prince George's county or Anne Arundel county.
* Have a residential working phone within their home.
* Be born in the United States.
* Speak English well enough to be interviewed.
* Be physically and mentally capable of performing the interview (i.e., must be able to hear the interviewer, mentally comprehend the interviewers questions and verbally respond).
* Never have been interviewed as a control for the study.
* Consent by the physician from the clinic where the subject was identified, or listed as the treating physician by the tumor registry or surgical pathology report.
* Report of a positive LDCT screen by a physician
* Hospital-Based Control Selection:
* Stratified to frequency match cases by age (5 year intervals), gender, race, smoking (20 pack year intervals -- non-smokers, 0-20, 20-40, 40-60 and greater than 60 and ex-smokers \[greater than 5 yrs\]) and hospital.
* Must reside in Baltimore city, contiguous metropolitan counties, Prince George's county or Anne Arundel county.
* Have a residential working phone within their home.
* Be born in the United States.
* Speak English well enough to be interviewed.
* Be physically and mentally capable of performing the interview (i.e., must be able to hear the interviewer, mentally comprehend the interviewers questions and verbally respond).
* Never have been interviewed as a control for the study.
* Physician consent by physician from clinic with subject is identified.
* Selection of Population-Based Controls:
* Stratified to match cases by age (5 year intervals), gender, and race.
* Must reside in Maryland
* Have a residential working phone within their home.
* Be born in the United States.
* Speak English well enough to be interviewed.
* Be physically and mentally capable of performing the interview (i.e., must be able to hear the interviewer, mentally comprehend the interviewers' questions and verbally respond).
* Never been interviewed as a control for the study.
EXCLUSION CRITERIA:
* Case Subject Selection:
* More than 6 months after initial diagnosis.
* Currently residing in an institution such as prison, nursing home or shelter.
* Severely ill in an intensive care unit (after discharge from ICU, then can be reconsidered).
* Subjects is unable to give informed consent.
* Hospital-Based Control Selection:
* History of cancer other than non-melanotic skin cancer or in situ cervical cancer.
* Currently residing in an institution such as a prison, nursing home or shelter.
* Severely ill in an intensive care unit (after discharge from ICU, the can be reconsidered).
* Subject is unable to give informed consent.
* Known diagnosis of HIV, hepatitis B or C.
* Selection of Population-Based Controls:
* History of cancer other than non-melanotic skin cancer or in situ cervical cancer.
* Currently residing in an institution such as a prison, nursing home or shelter.
* Subjects unable to give informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT00339859
Study Brief:
Protocol Section:
NCT00339859